Andrea K Steck
Overview
Explore the profile of Andrea K Steck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
2895
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Flammer E, Christopher M, Powers E, Broncucia H, Steck A, Gitelman S, et al.
medRxiv
. 2025 Mar;
PMID: 40034756
Objective: Identify microbial and microbiota-associated metabolites in monozygotic (MZ) and dizygotic (DZ) twins discordant for type 1 diabetes (T1D) to gain insight into potential environmental factors that may influence T1D....
2.
A type 1 diabetes prediction model has utility across multiple screening settings with recalibration
Templeman E, Ferrat L, Parikh H, You L, Triolo T, Steck A, et al.
Res Sq
. 2025 Feb;
PMID: 39975907
Background: Accurate type 1 diabetes prediction is important to facilitate screening for pre-clinical type 1 diabetes to enable potential early disease-modifying interventions and to reduce the risk of severe presentation...
3.
Phillip M, Achenbach P, Addala A, Albanese-ONeill A, Battelino T, Bell K, et al.
Diabetologia
. 2025 Feb;
PMID: 39934371
No abstract available.
4.
Calhoun P, Spanbauer C, Steck A, Frohnert B, Herman M, Keymeulen B, et al.
Diabetologia
. 2025 Feb;
PMID: 39934369
Aims/hypothesis: We aimed to assess whether continuous glucose monitor (CGM) metrics can accurately predict stage 3 type 1 diabetes diagnosis in those with islet autoantibodies (AAb). Methods: Baseline CGM data...
5.
Novel T Cell reactivities to Hybrid Insulin Peptides in Islet Autoantibody-Positive At-Risk Subjects
Hohenstein A, Gallegos J, Dang M, Groegler J, Broncucia H, Tensun F, et al.
Diabetes
. 2025 Jan;
PMID: 39820647
Type 1 Diabetes (T1D) is an autoimmune disease mediated by autoreactive T cells. Our studies indicate that CD4 T cells reactive to Hybrid Insulin Peptides (HIPs) play a critical role...
6.
Redondo M, Cuthbertson D, Steck A, Herold K, Oram R, Atkinson M, et al.
Diabetologia
. 2024 Dec;
68(3):588-601.
PMID: 39670998
Aims/hypothesis: Many studies of type 1 diabetes pathogenesis focus on individuals with high-risk HLA haplotypes. We tested the hypothesis that, among islet autoantibody-positive individuals, lacking HLA-DRB1*04-DQA1*03-DQB1*0302 (HLA-DR4-DQ8) and/or HLA-DRB1*0301-DQA1*0501-DQB1*0201 (HLA-DR3-DQ2)...
7.
Phillip M, Achenbach P, Addala A, Albanese-ONeill A, Battelino T, Bell K, et al.
Diabetes Care
. 2024 Sep;
47(11):2033.
PMID: 39240700
No abstract available.
8.
Phillip M, Achenbach P, Addala A, Albanese-ONeill A, Battelino T, Bell K, et al.
Diabetologia
. 2024 Sep;
67(9):2012-2014.
PMID: 39230637
No abstract available.
9.
You L, Ferrat L, Oram R, Parikh H, Steck A, Krischer J, et al.
Diabetologia
. 2024 Aug;
67(11):2507-2517.
PMID: 39103721
Aims/hypothesis: Although statistical models for predicting type 1 diabetes risk have been developed, approaches that reveal the heterogeneity of the at-risk population by identifying clinically meaningful clusters are lacking. We...
10.
Carry P, Vanderlinden L, Johnson R, Buckner T, Steck A, Kechris K, et al.
Front Immunol
. 2024 Jun;
15:1345494.
PMID: 38915393
Background: Type 1 diabetes (T1D) is preceded by a heterogenous pre-clinical phase, islet autoimmunity (IA). We aimed to identify pre vs. post-IA seroconversion (SV) changes in DNAm that differed across...